Sandoz is a global pharmaceutical company focused on generic and biosimilar medicines. It develops and supplies high-quality, affordable versions of off-patent drugs, with a portfolio of approximately 1,300 products available in over 100 countries. This includes a range of antibiotics, with more than 50 supplied worldwide, many of which are on the WHO Essential Medicines List.
The company's history spans over 135 years. In October 2023, Sandoz became a fully independent, publicly traded company following its spin-off from Novartis. Its stated purpose is to pioneer access to medicines for patients globally, with a focus on sustainable and innovative solutions within the pharmaceuticals and healthcare sectors.
